JOHNSON JOHN sold XERS
December 19, 2025 · Form 4 insider transaction
JOHNSON JOHN sold 135,400 shares of Xeris Biopharma Holdings, Inc. at $7.22 per share, a transaction worth $977.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
135,400
Price
$7.22
Total value
$977.0K
InsiderJOHNSON JOHN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 19, 2025
Filing dateDecember 19, 2025
Shares owned after698,083
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.200 to $7.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.